This disclosure generally relates to catheters, methods of enhancing the patency of an intravascular catheter and compositions, methods, devices and kits relating to the infusion of a catheter lock solution into an indwelling catheter. Disclosed compositions, methods, devices and kits aid in diminishing the effects of microbial infection in catheters and occlusion of the catheters. A representative lock solution includes about 10% sodium citrate and about 1.5% benzyl alcohol. The solution has a density approximating the density of blood for retention of the solution in a catheter during the lock period.

In a method for controlling unpleasant odors in discharge air from containers, rooms or plants in which strong smelling substances such as feces, waste or highly odorous foods are stored or processed, a fluid is introduced into the discharge air in a finely distributed form, which physically and/or chemically neutralizes the odor of the substances contained in the discharge air. The fluid is a 0.1% to 8% aqueous solution of an active substance concentrate which is 55-65 wt.-% triethylcitrate, 17.5 to 22.5 wt.-% 1,2 propanediol and 17.5 to 22 wt.- % di-propylene glycol-methylether. Alternatively, the fluid can also be a mixture of a suitable propellant gas mixture and the active substance concentrate specified above.

A sterilization system and method are provided that convert a sterilant solution to a vapor using an outgassing process that removes sterilant vapor from a solution (e.g., liquid) or a solid and delivers the sterilant vapor into an interior of an enclosure vessel. The interior of the enclosed vessel is maintained at a vacuum pressure. Once the sterilant vapor enters the interior of the vessel, the vapor expands to all surfaces to effectively sterilizing the interior of the vessel.

The present invention describes a method for disinfection and cleaning of at least one part of a device intended for recycling of water, said method involving flowing lactic acid, citric acid and/or an enzyme based or surfactant based solution into the part intended to receive the disinfection and cleaning.

An extracorporeal therapy system includes: (i) a dialysis fluid circuit including dialysis fluid preparation structure to prepare a dialysis fluid for treatment, the dialysis fluid circuit including a fresh dialysis fluid pump, a used dialysis fluid pump, and at least one filter for purifying the dialysis fluid; (ii) a blood circuit including a blood filter for use during the treatment; (iii) a blood pump operable to pump blood through the blood circuit and blood filter; (iv) a source of disinfecting fluid; and (v) a control unit operable with the dialysis fluid preparation structure and the blood pump, the control unit programmed to cause the disinfecting fluid to be delivered to and located for a duration at an area of the dialysis fluid circuit having the at least one purifying filter, and wherein during the duration the disinfecting fluid is precluded from contacting at least the fresh dialysis fluid pump.

Disclosed are compositions comprising Rhamnus prinoides (GESHO) extract or fragments thereof and methods of using Gesho extract for the inhibition of biofilm formation.

A multi-layer article including a first non-active state and a second active state, the multi-layer article comprising an outer layer having a first side and a second side, an inner layer adjacent to at least a portion of the outer layer and including a volatile material, and an upper layer including a first side and a second side, the first side of the upper layer being adjacent to at least a portion of the inner layer. The multi-layer article is folded upon itself in the first non-active state so that at least a first portion of the second side of the upper layer is disposed on a top of a second portion of the second side of the upper layer, and the first portion and the second portion of the upper layer are heat sealed in the non-active state.

A virucidal composition, a method of its manufacturing, related uses and end-user products are hereby provided. The composition includes a mixture of biologically active substances obtainable from selected fungal strains of Ganoderma lucidum (MUS12, MUS15, MUS18 and MUS23) by culturing the fungi in essentially liquid culture medium in a culture tank or a bioreactor in conditions essentially excluding agitation. The biologically active substances are obtained as a product excreted by mycelium of the above indicated G. lucidum strains and contain secondary metabolites, such as ganoderic acids and their derivatives. The composition has proved efficient in preventing the spread of viral infections. The composition can be used as a disinfecting agent for skin and nonliving surfaces and/or as an ingredient in preparation of personal care products.

A composition and method for reducing odors and cleaning packing media and other components in a wet air scrubber using nonionic surfactants, amphoteric surfactants, and a source of humic acid. Preferred nonionic surfactants include regular and low foam nonionic surfactants. The source of humic acid is preferably organic peat humus. The treatment composition is added to water in the wet scrubber at a concentration of 50-1000 ppm. The treatment composition is a premixed composition in a single container, making it unnecessary to separately add ingredients to the water. The treatment composition is effective at reducing odors by at least 50% compared to no treatment. The treatment composition is also effective at significantly reducing foam levels, making it unnecessary to add a separate defoamer to the water being treated. The treatment composition does not need to use defoamers, enzymes, oxidizers, chlorine compounds, or strong acids to be effective.

Systems and methods for air sanitization. The system includes a device configured to create aerosolized droplets of an antimicrobial formulation with an average particle size sufficiently small so that the formulation provides at least a 3-log reduction against Staphylococcus aureus or another target microbe within 60 minutes. The antimicrobial formulation includes one or more organic acids (e.g., lactic acid) and optionally one or more diols (e.g., 1,2-hexanediol). Where both are included, the organic acid(s) and diol(s) may have a vapor pressure of at least 0.02 Pa. Where just the organic acid is included, the organic acid has a vapor pressure of at least 0.10 Pa. The formulation may further include a buffer, a surfactant, water, a fragrance, etc. The formulation may be delivered as an aerosol, using a pump sprayer, a mister, a nebulizer, a vaporizer, a cold fogger, a thermal fogger, an ultrasonic dispensing device, an electrostatic sprayer, etc.